ifenprodil has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
ifenprodil: NMDA receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trippier, PC | 1 |
| Jansen Labby, K | 1 |
| Hawker, DD | 1 |
| Mataka, JJ | 1 |
| Silverman, RB | 1 |
| Rui, M | 1 |
| Rossino, G | 1 |
| Coniglio, S | 1 |
| Monteleone, S | 1 |
| Scuteri, A | 1 |
| Malacrida, A | 1 |
| Rossi, D | 1 |
| Catenacci, L | 1 |
| Sorrenti, M | 1 |
| Paolillo, M | 1 |
| Curti, D | 1 |
| Venturini, L | 1 |
| Schepmann, D | 1 |
| Wünsch, B | 1 |
| Liedl, KR | 1 |
| Cavaletti, G | 1 |
| Pace, V | 1 |
| Urban, E | 1 |
| Collina, S | 1 |
| Mazumder, MK | 1 |
| Borah, A | 1 |
1 review available for ifenprodil and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; | 2013 |
2 other studies available for ifenprodil and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents.
Topics: Acetylcholinesterase; Animals; Antioxidants; Blood-Brain Barrier; Cell Survival; Cholinesterase Inhi | 2018 |
Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.
Topics: Allosteric Site; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Calcium; Cells, Cultured; Human | 2014 |